Distribuição do pertuzumabe

Simple item page
dc.TypeRevistas/Boletinspt_BR
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva
dc.contributor.authorInstituto Nacional de Câncer (Brasil)
dc.contributor.authorINCA
dc.contributor.authorSistema Único de Saúde (Brasil)
dc.contributor.authorBrasil. Ministério da Saúde
dc.date.accessioned2021-08-03T15:31:02Z
dc.date.available2021-08-03T15:31:02Z
dc.date.issued2020-07
dc.description3 p.: tab. p&b.
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/3567
dc.language.isootherpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno IV, n. 39.
dc.subjectAnticorpos Antineoplásicospt_BR
dc.subjectAntibodies, Neoplasmpt_BR
dc.subjectGenes erbB-2
dc.subjectGenes, erbB-2
dc.subjectPertuzumabe
dc.subjectAnticuerpos Antineoplásicos
dc.titleDistribuição do pertuzumabept_BR

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Informe-sus-onco-Julho-2020.pdf
Size:
460.66 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Informe SUS - ONCO 2020